Celltrion stock

When OneAsia Partners, a Seoul-based private equity fund operator, revised part of its PEF Havana I’s articles of association on Feb. 14, 2023...

South Korea’s leading biosimilar developer Celltrion Inc. will break ground on its first contract development and manufacturing organization (...

South Korean pension funds continued their Kospi market buying spree for a fourth straight month in November, notching their largest net purchases o...

Celltrion Inc.'s Remsima, the world’s first biosimilar monoclonal antibody, is on track to exceed 1 trillion won ($713 million) in sales this ...

South Korea’s Young Poong Corp., embroiled in a fierce management control dispute with Korea Zinc Inc., is now the target of an activist fund ...

South Korea's Celltrion Inc. announced on Thursday that it decided to repurchase additional treasury shares worth 100 billion won ($71.6 million).Fr...

The lackluster South Korean stock market and softening Korean currency have discouraged local companies from raising money at home and pushed some t...

South Korea's Celltrion Inc. said on Friday that it completed its acquisition of iQone Healthcare Switzerland, a Swiss pharmaceutical distributor, t...

South Korea’s crypto exchanges are enjoying a global boom in virtual currencies, including bitcoin, as US President-elect Donald Trump is expe...

South Korea's Shinhan Securities said on Thursday its overseas subsidiary Shinhan Securities Vietnam (SSV) launched a mobile trading system (MTS) "N...

The US stock holdings of South Korean individual investors surpassed $100 billion for the first time, driven by a sustained rally in the US markets ...

South Korea's mom-and-pop investors have upped their stake in Indian stocks, hoping that Donald Trump's return to the White House will boost the Sou...

MSCI announced on Wednesday that South Korea's Hyundai Rotem Co. will be added to the Morgan Stanley Capital International (MSCI) Korea Index. ...

South Korea's Celltrion Inc. said on Monday it released Steqeyma (ustekinumab) in Europe, the biosimilar of autoimmune disease treatment Stelara.T...

South Korean investors are hoarding cash as Samsung Electronics Co., the world’s top memory chipmaker, hurts local stocks and uncertainties ov...

South Korean biosimilar maker Celltrion Inc. said on Monday its subcutaneous injection formulation for autoimmune diseases, Zymfentra (infliximab), ...

India’s stock market is gearing up for a leap thanks to an influx of retail investors seeking better returns and the lower barriers for small ...

KB Financial Group Inc., South Korea’s largest financial holding group, is set to use its excess capital for share buybacks and dividends next...

LG Electronics Inc., the world’s largest home appliances maker, on Tuesday announced plans to unlock value by accelerating its transformation ...

South Korea’s plant and machinery powerhouse Doosan Group will resume the merger of Doosan Bobcat Inc. and Doosan Robotics Inc. using a new me...

Celltrion Inc., South Korea’s largest biosimilar maker, said on Friday it plans to establish a contract development and manufacturing organiza...

Hyundai Motor Co. and Kia Corp., South Korea’s two largest carmakers, are likely to face disruptions in local production as their auto parts s...

South Korea's KB Kookmin Bank said on Tuesday that it issued €500 million ($545 million) in global covered bonds the previous day.Covered bonds...

Foreign investors' appetite for South Korean stocks turned sour with sales of 7.36 trillion won ($5.5 billion) worth of shares on the Korean bourse ...

South Korea’s Celltrion Inc. said on Friday that its cancer treatments have captured a 90% market share in several Central American countries....

LG Energy Solution Ltd., the world’s third-largest electric vehicle battery manufacturer, is set to supply cells to Mercedes-Benz AG, a German...

South Korea's Mirae Asset Securities Co. said on Monday that it has established an AI Market Assistant system, in which artificial intelligence (AI)...

South Korea’s leading internet portal operator Naver Corp. will buy back and retire about 400 billion won ($306 million) worth of shares by th...

Celltrion Inc., South Korea’s largest biosimilar maker, said on Monday that it completed the establishment of a local subsidiary in Vietnam....

South Korea’s securities exchange operator, Korea Exchange, launched a new corporate value-up index on Tuesday, a key plank for the government...